The synthesis of a new series of 1β-methylcarbapenems having spiro[2,4]heptane moieties is described. Their in vitro antibacterial activities against both Gram-positive and Gram-negative bacteria were tested and the effect of substituents at the pyrrolidine ring was investigated. Most of the compounds were found to be more active compared to imipenem against Gram-negative bacteria. A particular compound (IIIc) having 7-oxo-5-azaspiro [2, 4] heptane moiety showed the most potent antibacterial activity.
Introduction
Carbapenems are one of the most potent types of antibacterial agents and are among those used as last resort against infections in the clinical field. Three carbapenems, imipenem, 1,2 meropenem 3 and ertapenem 4 have been marketed so far. It was revealed that 1β-methylcarbapenems showed not only a broad antibacterial spectrum against both Gram-positive and Gram-negative bacteria but also high stability to human renal DHP-I. 5, 6 The carbapenem compounds having (3S)-pyrrolidin-3-ylthio group at the C-2 position in the carbapenem skeleton are noted for their broad and potent antibacterial activity, 7 and therefore a large number of these derivatives have been synthesized and investigated. [8] [9] [10] [11] [12] At present, several carbapenem derivatives such as S-4661, 13 BO-2727 14 and E-1010 15 are under clinical or preclinical studies since the launch of meropenem.
In this paper, we describe the synthesis and structureactivity relationships of carbapenems having spiro [2, 4] heptane moieties and our approach for improvement of the antibacterial activity of the carbapenem is discussed. It has been reported that an spiro [2, 4] heptane substituent could enhance largely the activity of quinolone antibiotics especially against Gram-positive and Gram-negative bacteria. 16, 17 Based on this fact, a positive effect of a spiro [2, 4] heptane moiety on the activity of carbapenem was anticipated.
Results and Discussion
Chemistry. Our synthetic route for the new carbapenems involved the preparation of appropriately protected thiols containing pyrrolidine ring as a side chain and subsequent coupling reaction with a carbapenem diphenylphosphate, followed by deprotection of the resulting protected carbapenems.
7,7-Ethylenedioxy-5-azaspiro [2, 4] heptane (8) was prepared via seven steps from diketene and benzylamine as shown in Scheme 1. 18 The intermediate 11 was obtained by treatment of the hydroxy compound 9 19 with 7,7-ethylenedioxy-5-azaspiro- [2, 4] heptane (8) using p-toluenesulfonyl chloride, followed by hydrolysis with acid. The intermediate 11 was converted to the hydroxy compound 12 by treatment of sodium borohydride in THF. Preparation of the oxime 13 was accomplished by treatment of compound 11 with hydroxyl amine (Scheme 2).
The oxime 13 was converted to the methoxyimino 14, ethyloxyimino 15 and allyloxyimino 16 by treatment with methyl iodide, ethyl bromide and allyl bromide respectively, in the presence of potassium hydroxide (Scheme 3).
Replacement of the hydroxy group in compound 12 with fluoro moiety in compound 17 was accomplished by treatment of 12 with DAST in CH 2 Cl 2 (Scheme 4).
The oxime 13 was converted to the intermediate amine by reduction with lithium aluminum hydride in THF and subsequent treatment with allyl chloroformate to provide 18 (Scheme 5).
Deprotection of trityl group in mercaptanes Ia-h was achieved by treatment of 11-18 with trifluoroacetic acid in the presence of triethylsilane.
Finally, the reaction of 19 with thiols Ia-h in the presence of diisopropylethylamine gave the corresponding 2-substituted carbapenems (IIa-h). Deprotection of IIa-h by Scheme 1. i) benzylamine, EDC. ii) dibromoethane, K2CO3, DMF. iii) ethylenglycol, p-toluensulfonic acid, Benzene. iv) Br2, dioxane, ether. v) NaH, DMF. vi) LAH, THF. vii) Pd/C, H2, EtOH. treatment with tetrakis(triphenylphosphine)palladium(0) and tributyltin hydride gave the crude products, which were purified by HP-20 column to give the pure carbapenems (IIIa-h) (Scheme 6).
Antibacterial activity. The MIC was determined by the agar dilution method using test agar. An overnight culture of bacteria in tryptosoy broth was diluted to about 10 6 cells/mL with the same broth and inoculated with an inoculating device onto agar containing serial two fold dilutions of the test compounds. Organisms were incubated at 37 o C for 18-20 hours. The MICs of a compound were defined as the lowest concentration that visibly inhibited growth.
The in vitro antibacterial activities of new carbapenems (IIIa-h) prepared above against both Gram-positive and Gram-negative bacteria are listed in Table 1 . For comparison, the MIC values of imipenem are also listed. All the compounds displayed superior or similar antibacterial activities to imipenem against Gram-negative bacteria except IIIe and compounds IIIc and IIIg showed similar antibacterial activities to imipenem against Gram-positive bacteria. In particular, against Escherichia coli, Klebsiella peneumoniae, Citrobacter freundii and Enterobactor cloaca, most of the compounds except compounds IIIe-f and IIIh were showed to be 2-4 times more active than imipenem.
By comparing the effect of sustituents at C-5 of the pyrrolidine side chain on activity, it was found Unexpectedly that compounds IIIa and IIIh having hydroxy and amino groups respectively didn't show good activity compared to other compounds. In case of compounds IIId, IIIe, and IIIf, with increasing of bulkiness from methoxy, ethoxy to allyloxy, their activities decreased in order.
As a result, among all of these derivatives, compound IIIc having 7-oxo-5-azaspiro [2, 4] heptane moiety showed the most potent antibacterial activity while the fluoro substituted compound IIIg exhibited the most potent activity against Haemophilus influenzae.
Experimental
-Melting point (mp): Thomas Hoover apparatus, uncorrected. -UV spectra: Hewlett Packard 8451A UV-VIS spectrophotometer. -IR spectra: Perkin Elmer 16F-PC FT-IR. -NMR spectra:Varian Gemini 300 spectrometer, tetramethylsilane (TMS), as an internal standard. The LC/MS system consisted of an HP 1100 series binary pump HPLC system (Agilent, Palo Alto, CA, USA) and an LC/MSD iontrap mass spectrometer equipped with an electrospray ionization source (Agilent, Palo Alto, CA, USA). To a solution of 9 (5.4 g, 11.8 mmol) in dry CH 2 Cl 2 (10 mL) was added drop-wise triethylamine (2.5 mL, 17.7 mmol) and p-toluensulfonyl chloride (2.7 g, 14.2 mmol) at 0 °C and mixture was stirred for 6 hr at the same temperature. The reaction solution was neutralized with 10% NaHCO 3 and washed with water, brine, and dried over MgSO 4 . The organic layer was concentrated in vacuo to give a residue, which was used without further purification. To a solution of 8 (3.1 g, 20.0 mmol) in dry DMF (30 mL) was added dropwise triethylamine (3.0 mL, 22.0 mmol) and tosyl residues, and then was stirred for 10 h at 80 °C. The reaction mixture was diluted with ethyl acetate (100 mL) and water (50 mL), and then the organic layer was dried over anhydrous Na 2 SO 4 . The solvent was removed in vacuo, and purification was achieved by flash chromatography (EaOAC:hexane = 1:3) to afford 10 (5.0 g, 70%). (
2S,4S)-2-[(7-Methoxyimino-5-azaspiro[2.4]heptane)-methyl]-4-tritylthio-1-(allyloxycarbonyl)pyrrolidine 14.
To a solution of 13 (0.5 g, 0.8 mmol) in dry DMF (10 mL) was added portionwise KOH (82.6 mg, 1.4 mmol), methyl iodide (0.05 mL, 0.78 mmol) and the mixture was stirred for 2 h at ice bath. The reaction mixture was diluted with ethyl acetate (50 mL) and water (30 mL), and then the organic layer was dried over anhydrous Na 2 SO 4 . The solvent was removed in vacuo, and purification was achieved by flash chromatography (EaOAC:hexane = 1:5) to afford 14 (0.44 g, 71%). 2 mmol) at ice bath and was refluxed for 4 h. The reaction mixture was added ice water (2.0 mL), 15% NaOH (2.0 mL) and filtered off. The filtrate was concentrated under reduced pressure, and the residue was dissolved in chloroform and washed with water and brine. Evaporation of the solvent in vacuo gave a crude residue, which was used without further purification. A solution of the above residue in dry CH 2 Cl 2 (20 mL) was cooled to 0 o C under nitrogen and treated with allyl chloroformate (0.2 g, 1.5 mmol). The mixture was stirred at room temperature for 1 h, diluted with CH 2 Cl 2 (200 mL), and washed with 10% NaHCO 3 and brine. The organic layer was dried over anhydrous Na 2 SO 4 . Purification was achieved by silica gel column chromatography (EtOAc:n-Hexane = 1:3) to give 18 (0.46 g, 56%) as a pale yellow oil. pyrrolidin-3-ylthio]-1-methylcarbapen-2-em-3 -carboxylate IIa. To a solution of 12 (0.5 g, 0.9 mmol) in CH 2 Cl 2 (5 mL) triethylsilane (0.35 mL, 2.2 mmol) was added dropwise followed by TFA (1.2 mL) at 5 o C. After stirring for 30 min at room temperature, the mixture was evaporated under reduced pressure. The residue was dissolved with ethyl acetate and washed with 10% NaHCO 3 and brine. The organic layer was concentrated in vacuo to give a residue (Ia), which was used without further purification. A solution of allyl (1R,5S,6S)-2-(diphenylphosphoryloxy)-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylate (19, 0.50 g, 1.0 mmol) in CH 3 CN (10 mL) was cooled to 0 under N 2 . To this solution was added diisopropylethyl amine (0.13 g, 1.0 mmol) and a solution of the mercapto compound Ia in CH 3 CN (5 mL). After stirring for 5 h, the mixture was diluted with ethyl acetate, washed with 10% NaHCO 3 , brine, and dried over anhydrous MgSO 4 . Evaporation in vacuo gave a foam, which was purified by silica gel chromatography (EtOAc:n-Hexane = 3:1) to give IIa (46 mg, 19%) as a yellow amorphous solid. The synthesis of compounds IIb-h was carried out by the same procedure described for the preparation of IIa.
Allyl(1R,5S,6S)-6-[(1R)-hydroxyethyl]-2-[[5-(7-hydroxy-5-aza-spiro[2.4]heptane)methyl]-1-(allyloxycarbonyl)-
IIb: Yield 13%. C and was stirred for 1 h at same temperature. The resulting solution was diluted with water (10 mL) and the organic layer was further washed with water (2 × 10 mL). The combined aqueous layers were washed with ethyl ether (2 × 10 mL) and lyophilized to give a yellow powder which was purified on a Diaion HP-20 column using eluting system of 2% THF in water. Fractions having UV absorption at 298 nm were collected and lyophilized again to give the title compound IIIa as a amorphorus solid. Yield 34%. UV λ max : 298 nm. 
